Get Regular Updates!


The business of medicinal cannabis

The business of medicinal cannabis

A WA company is set to harvest its first legal cannabis crop next month, destined for the medical market.

The business of medicinal cannabis

Perth-based medicinal cannabis business AusCann has recently partnered with a Chilean group to produce the crop in South America.

The 400 plants, across eight strains, are being grown on a 30-hectare facility south of Santiago.

The crop was planted in November, and the first harvest is expected in April.

AusCann says the plants will be sold to third parties for use in a range of clinical trials later this year.

When combined with their links to medicinal cannabis growing groups in Canada and Europe, AusCann is well set up to be a major player in the global sector.


Cannabis contains more than 60 psychoactive chemicals.

One of these is THC, which is found in the resin covering the flowering tops and upper leaves of the female plant.

THC is the chemical that alters mood and produces the feeling of a ‘high’.

Cannabis also contains cannabidiol, which can offset the effects of THC.

Proponents of the medical cannabis point to success in treating epilepsy and multiple sclerosis.

It can be used in patients with chronic pain, Parkinson’s disease and more.

Cannabis may also relieve nausea and vomiting in cancer patients undergoing chemotherapy.

But doctors have been cautious in their support of medicinal cannabis.

The Australian Medical Association has stressed that any promotion of the medical use of cannabis must go hand in hand with education on the risks of non-medical use.



AusCann and other medicinal cannabis companies are poised to capitalise on a series of recent legislative shifts.

These aim to facilitate access to marijuana for patients with a genuine medical need.

Changes to the Narcotic Drugs Act passed in February 2016 paved the way for legally grown cannabis plants to be made into pharmaceutical products in Australia.

Last month the Federal Government streamlined the importation process.

In WA, it became legal for chemists to sell medical cannabis to people with a prescription on 1 November 2016.

Doctors could prescribe cannabis to patients from the same date.

But they must first get approval from both the Therapeutic Goods Administration and a Department of Health committee.

It remains illegal to cultivate cannabis for recreational use.


WA’s climate is ideal for growing cannabis and the State could see a hefty slice of the medical cannabis pie.

AusCann, which boasts heavy-hitting board members including former WA attorney-general Cheryl Edwardes and former Liberal MP Mal Washer, is keen to grow cannabis in WA.

Another local company, MGC Pharma, could do the same.

Any growing operation will be subject to security measures including walls or fences, CCTV and alarms.

AusCann is banking on measures to distinguish its legally grown cannabis from illegal supplies.

It has reportedly hired forensic science firm Source Certain to maintain supply chain integrity.

AusCann also signed a five-year research agreement with Murdoch University in May 2016.

The partnership will develop medical cannabis strains suited to Australian growing conditions.

Particle Puns


Creative Commons Logo

Republishing our content

We want our stories to be shared and seen by as many people as possible.

Therefore, unless it says otherwise, copyright on the stories on Particle belongs to Scitech and they are published under a Creative Commons Attribution-NoDerivatives 4.0 International License.

This allows you to republish our articles online or in print for free. You just need to credit us and link to us, and you can’t edit our material or sell it separately.

Using the ‘republish’ button on our website is the easiest way to meet our guidelines.


You cannot edit the article.

When republishing, you have to credit our authors, ideally in the byline. You have to credit Particle with a link back to the original publication on Particle.

If you’re republishing online, you must use our pageview counter, link to us and include links from our story. Our page view counter is a small pixel-ping (invisible to the eye) that allows us to know when our content is republished. It’s a condition of our guidelines that you include our counter. If you use the ‘republish’ then you’ll capture our page counter.

If you’re republishing in print, please email us to let us so we know about it (we get very proud to see our work republished) and you must include the Particle logo next to the credits. Download logo here.

If you wish to republish all our stories, please contact us directly to discuss this opportunity.


Most of the images used on Particle are copyright of the photographer who made them.

It is your responsibility to confirm that you’re licensed to republish images in our articles.


All Particle videos can be accessed through YouTube under the Standard YouTube Licence.

The Standard YouTube licence

  1. This licence is ‘All Rights Reserved’, granting provisions for YouTube to display the content, and YouTube’s visitors to stream the content. This means that the content may be streamed from YouTube but specifically forbids downloading, adaptation, and redistribution, except where otherwise licensed. When uploading your content to YouTube it will automatically use the Standard YouTube licence. You can check this by clicking on Advanced Settings and looking at the dropdown box ‘License and rights ownership’.
  2. When a user is uploading a video he has license options that he can choose from. The first option is “standard YouTube License” which means that you grant the broadcasting rights to YouTube. This essentially means that your video can only be accessed from YouTube for watching purpose and cannot be reproduced or distributed in any other form without your consent.


For more information about using our content, email us:

Copy this HTML into your CMS
Press Ctrl+C to copy

We've got chemistry. Want something physical?